AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 33 filers reported holding AGILE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $37,000 | -80.2% | 75,454 | -46.2% | 0.00% | – |
| Q2 2021 | $187,000 | +356.1% | 140,364 | +608.1% | 0.00% | – |
| Q1 2021 | $41,000 | -86.4% | 19,824 | -81.7% | 0.00% | – |
| Q2 2020 | $302,000 | +344.1% | 108,532 | +195.6% | 0.00% | – |
| Q1 2020 | $68,000 | +142.9% | 36,718 | +233.3% | 0.00% | – |
| Q4 2019 | $28,000 | +366.7% | 11,016 | -27.6% | 0.00% | – |
| Q3 2018 | $6,000 | – | 15,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 15,919,925 | $33,113,000 | 0.42% |
| INVESTOR AB | 3,510,189 | $7,301,000 | 0.26% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $1,529,000 | 0.21% |
| FIRST MIDWEST BANK TRUST DIVISION | 578,864 | $1,204,000 | 0.17% |
| PREMIER ASSET MANAGEMENT LLC | 224,559 | $467,000 | 0.08% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 100,000 | $208,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 140,015 | $291,000 | 0.05% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 25,000 | $52,000 | 0.01% |
| Kalos Management, Inc. | 19,250 | $35,000 | 0.01% |
| Founders Capital Management | 5,000 | $10,000 | 0.01% |